BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9802455)

  • 1. Central nervous system reactions associated with famotidine: report of five cases.
    Odeh M; Oliven A
    J Clin Gastroenterol; 1998 Oct; 27(3):253-4. PubMed ID: 9802455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human gastric carcinoid detected during long-term antiulcer therapy of H2 receptor antagonist and proton pump inhibitor.
    Haga Y; Nakatsura T; Shibata Y; Sameshima H; Nakamura Y; Tanimura M; Ogawa M
    Dig Dis Sci; 1998 Feb; 43(2):253-7. PubMed ID: 9512115
    [No Abstract]   [Full Text] [Related]  

  • 3. [Efficacy of gastrosidine (famotidine) in the treatment of gastroesophageal reflux at the reflux esophagitis stage].
    Vasil'ev IuV; Li IA
    Eksp Klin Gastroenterol; 2002; (4):30-3, 131. PubMed ID: 12503271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical aspects of Kvamatel (famotidine) administration].
    Golochevskaia VS
    Klin Med (Mosk); 1996; 74(1):45-7. PubMed ID: 8649009
    [No Abstract]   [Full Text] [Related]  

  • 5. Famotidine-induced retinopathy.
    Lee YC; Wang CC
    Eye (Lond); 2006 Feb; 20(2):260-3. PubMed ID: 15761479
    [No Abstract]   [Full Text] [Related]  

  • 6. Safety profile of H2-receptor antagonists: current status of famotidine.
    Levine JB
    J Int Med Res; 1989; 17 Suppl 1():48A-53A. PubMed ID: 2566543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Famotidine: clinical applications of a new H2-receptor antagonist. May 16, 1986, Carmel, California.
    Am J Med; 1986 Oct; 81(4B):1-64. PubMed ID: 2877568
    [No Abstract]   [Full Text] [Related]  

  • 8. Famotidine-associated delirium. A series of six cases.
    Catalano G; Catalano MC; Alberts VA
    Psychosomatics; 1996; 37(4):349-55. PubMed ID: 8701013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. H(2)-histamine antagonist (famotidine) induced adverse CNS reactions with long-standing secondary mania and epileptic seizures.
    von Einsiedel RW; Roesch-Ely D; Diebold K; Sartor K; Mundt C; Bergemann N
    Pharmacopsychiatry; 2002 Jul; 35(4):152-4. PubMed ID: 12163986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of upper gastro-intestinal bleeding with the H2-receptor antagonist famotidine.
    Aoki T
    J Int Med Res; 1989; 17 Suppl 1():32A-40A. PubMed ID: 2566542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Famotidine to prevent peptic ulcer caused by NSAIDs.
    Singh G; Fries JF
    N Engl J Med; 1996 Oct; 335(17):1322; author reply 1322-3. PubMed ID: 8992334
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of H2-receptor antagonist- and proton-pump inhibitor-based triple regimens for the eradication of Helicobacter pylori in Chinese patients with gastritis or peptic ulcer.
    Hu FL; Jia JC; Li YL; Yang GB
    J Int Med Res; 2003; 31(6):469-74. PubMed ID: 14708410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Famotidine-associated mental status changes.
    Rodgers PT; Brengel GR
    Pharmacotherapy; 1998; 18(2):404-7. PubMed ID: 9545163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Famotidine for the prevention of peptic ulcers and oesophagitis in patients taking low-dose aspirin (FAMOUS): a phase III, randomised, double-blind, placebo-controlled trial.
    Taha AS; McCloskey C; Prasad R; Bezlyak V
    Lancet; 2009 Jul; 374(9684):119-25. PubMed ID: 19577798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complete atrioventricular block and cardiac arrest following intravenous famotidine administration.
    Schoenwald PK; Sprung J; Abdelmalak B; Mraović B; Tetzlaff JE; Gurm HS
    Anesthesiology; 1999 Feb; 90(2):623-6. PubMed ID: 9952172
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug therapy of peptic ulcer disease.
    Ching CK; Lam SK
    Br J Hosp Med; 1995 Jul 12-Aug 15; 54(2-3):101-6. PubMed ID: 7551483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Famotidine-associated central nervous system reactions and plasma and cerebrospinal drug concentrations in neurosurgical patients with renal failure.
    Yoshimoto K; Saima S; Echizen H; Nakamura Y; Kondo T; Yagishita Y; Ishizaki T
    Clin Pharmacol Ther; 1994 Jun; 55(6):693-700. PubMed ID: 8004885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [UV spectrophotometric assay of famotidine in combination with picrolonic acid, picrolinate].
    Apostu M; Bibire N; Dorneanu V
    Rev Med Chir Soc Med Nat Iasi; 2005; 109(2):422-5. PubMed ID: 16607813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of famotidine-induced aseptic meningitis].
    Ishihara O; Omata T
    Rinsho Shinkeigaku; 2000 Jan; 40(1):48-50. PubMed ID: 10825801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of famotidine in adult patients with end-stage renal disease: assessment of dosing and mental status changes.
    Redmond AM; Pentapaty N; Weibel J; Nolan SF; Hudson JQ; Self T
    Am J Med Sci; 2005 Jul; 330(1):8-10. PubMed ID: 16020993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.